Gundersen Lutheran Renal Dialysis - Viroqua in Viroqua, Wisconsin - Dialysis Center

Gundersen Lutheran Renal Dialysis - Viroqua is a medicare approved dialysis facility center in Viroqua, Wisconsin and it has 12 dialysis stations. It is located in Vernon county at 407 S Main St, Viroqua, WI, 54665. You can reach out to the office of Gundersen Lutheran Renal Dialysis - Viroqua at (608) 637-4376. This dialysis clinic is managed and/or owned by Gundersen Lutheran. Gundersen Lutheran Renal Dialysis - Viroqua has the following ownership type - Non-Profit. It was first certified by medicare in September, 1998. The medicare id for this facility is 523517 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameGundersen Lutheran Renal Dialysis - Viroqua
Location407 S Main St, Viroqua, Wisconsin
No. of Dialysis Stations 12
Medicare ID523517
Managed ByGundersen Lutheran
Ownership TypeNon-Profit
Late Shifts No

Contact Information


407 S Main St, Viroqua, Wisconsin, 54665
(608) 637-4376

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Gundersen Lutheran Renal Dialysis - Viroqua from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1003159195
Organization NameGlmc Viroqua Renal Dialysis
Doing Business AsGundersen Lutheran Medical Center Inc
Address407 S Main St Ste 300 Viroqua, Wisconsin, 54665
Phone Number(608) 782-7300

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data17
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL6

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center29
    Adult patient months included in Kt/V greater than or equal to 1.2283
    Percentage of adult patients getting regular hemodialysis at the center100
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

    King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

    Scientists identify how cell architecture changes during formation of gametes

    Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

    New drug combination proves effective in treating patients with HCV genotype 1

    Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

    Hope For Heroes Foundation forms national alliance with USA Medical Card

    Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

    Read more Medical News

    › Verified 2 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Gundersen Lutheran Renal Dialysis - Viroqua with elevated calcium levels.

Patients with hypercalcemia30
Hypercalcemia patient months286
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor33
Patients with Serumphosphor less than 3.5 mg/dL15
Patients with Serumphosphor from 3.5 to 4.5 mg/dL42
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL13
Patients with Serumphosphor greater than 7 mg/dL2

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 22
Patient months included in arterial venous fistula and catheter summaries 203
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment73
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer13

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary26
Hospitalization Rate in facility61.4 (As Expected)
Hospitalization Rate: Upper Confidence Limit236.3
Hospitalization Rate: Lower Confidence Limit17.7

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Gundersen Lutheran Renal Dialysis - Viroqua were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate: Upper Confidence Limit27.9

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Gundersen Lutheran Renal Dialysis - Viroqua get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.37 (As Expected)
SIR: Upper Confidence Limit1.83
SIR: Lower Confidence Limit.02

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Gundersen Lutheran Renal Dialysis - Viroqua's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 23
Transfusion Rate in facility36.7 (As Expected)
Transfusion Rate: Upper Confidence Limit178.3
Transfusion Rate: Lower Confidence Limit9.2

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Gundersen Lutheran Renal Dialysis - Viroqua lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary157
Mortality Rate in facility13.1 (As Expected)
Mortality Rate: Upper Confidence Limit19
Mortality Rate: Lower Confidence Limit8.7

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago


Dialysis Facility in Viroqua, WI

Gundersen Lutheran Renal Dialysis - Viroqua
Location: 407 S Main St, Viroqua, Wisconsin, 54665
Phone: (608) 637-4376

News Archive

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions.

Read more Medical News

› Verified 2 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.